La tuberculosis (TB) era la primera causa de mortalidad infecciosa mundial hasta la
pandemia de COVID-19. Afecta sobre todo a los países en vías de desarrollo (PVD) …

Diabetes Mellitus increases the risk of developing Tuberculosis (TB) disease by about three
times; it also doubles the risk of death during TB treatment and other poor TB treatment …

Background Multidrug-resistant tuberculosis had high treatment failure and mortality.
Success rate of treatment currently 56% at global level, 48% in Indonesia and 36% in West …

Recent advances in bacterial whole-genome sequencing have resulted in a comprehensive
catalog of antibiotic resistance genomic signatures in Mycobacterium tuberculosis. With a …

Introduction We aimed to explore the real-world clinical application value and challenges of
metagenomic next-generation sequencing (mNGS) for pulmonary infection diagnosis …

Background Diabetes was identified as a tuberculosis (TB) risk factor mostly in retrospective
studies with limited assessments of metabolic variables. The prospective Effects of Diabetes …

Abstract Background Early clearance of Mycobacterium tuberculosis is the eradication of
infection before an adaptive immune response develops. We aimed to identify host factors …

Diabetes is a major risk factor for tuberculosis (TB). Diabetes increases the risk of the
progression from latent tuberculosis infection (LTBI) to active pulmonary TB and TB patients …

Tuberculosis (TB) and type 2 diabetes mellitus (DM), a major TB risk factor, are both
accompanied by marked alterations in metabolic processes. Dissecting the specific …

Background People with diabetes have an increased risk of developing active tuberculosis
(TB) and are more likely to have poor TB-treatment outcomes, which may impact on control …